| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |